The EGShares Financials GEMS (NYSEArca:FGEM), a fund that
invests in large emerging market companies in the financials
industry, was No. 1 on IndexUniverse's "Bottom 10 1-Day Performers"
list, with 5.15 percent in losses.
GEMS was one of a number of emerging market funds that fell on
Friday, as investors have become concerned about a bubble in
developing countries fueled in part by overstretched European
lenders.
The db-X MSCI Brazil Currency-Hedged Equity (NYSEArca:DBBR) was
No. 5 on the list, with 3.31 percent in losses. The Market Vectors
China (NYSEArca:PEK) was No. 9 on the list, with 2.84 percent in
losses.
The PowerShares KBW Capital Markets Portfolio (NYSEArca:KBWC), a
fund that holds broker-dealers, asset managers, trust and custody
banks, was No. 2 on the bottom-performers list, with 4.55 percent
in losses-a victim perhaps of increased worries about the
implications of JP Morgan's trading losses last week.
Agriculture-related commodity ETFs also were hit hard on Friday,
spurred by concerns about slowing global growth.
The iPath Dow Jones-UBS Cotton Total Return ETN (NYSEArca:BAL)
was No. 3 on the bottom performers list, returning 3.57 percent in
losses.
Top Performers
The C-Tracks Exchange-Traded Notes on the Citi Volatility
(NYSEArca:CVOL) was No. 1 on IndexUniverse's "Top 10 1-Day
Performers" list-one of a number of volatility-related funds that
benefitted from investor conerns about the stability of the
eurozone and the implications of JP Morgan's trading loss.
The iPath S&P 500 VIX Mid-Term Futures ETN (NYSEArca:VXZ)
was No. 4 on the top performers, list with 1.71 percent in
gains.
The iPath S&P VIX Short-Term Futures ETN (NYSEArca:VXX) was
No. 6 on the list, with 1.57 percent in gains. The VelocityShares
VIX Short Term ETN (NYSEArca:VIIX) was No. 8 on the list, with 1.42
percent in gains.
Biotech ETFs also surged on Friday, in part due to last week's
announcement by Vertex Pharmaceuticals of a study showing positive
results for a new treatment for cystic fibrosis.
The SPDR S&P Biotech ETF (NYSEArca:XBI) was No. 3 on the top
performers list, with 1.75 percent in gains.
Also, the Market Vectors Biotech ETF (NYSEArca:BBH) was No. 9 on
the list, with 1.34 percent in gains. The iShares Nasdaq
Biotechnology Index Fund (NYSEArca:IBB) was No. 10 on the list,
with 1.33 percent in gains.
Top 10 1-Day Performers, Excluding Leverage/Inverse Funds and
'lt;1,000 Shares Traded
| Ticker |
Name |
1-Day Performance |
1-Day Volume |
AUM ($, mm) |
| CVOL |
C-Tracks Exchange-Traded Notes on the Citi
Volatility |
2.92% |
13,170 |
8.26 |
| EEME |
iShares MSCI Emerging Markets EMEA Index |
2.11% |
10,200 |
10.38 |
| XBI |
SPDR S&P Biotech |
1.75% |
784,665 |
548.76 |
| VXZ |
iPath S&P 500 VIX Mid-Term Futures ETN |
1.71% |
339,647 |
224.65 |
| ZROZ |
PIMCO 25+ Year Zero Coupon U.S. Treasury |
1.61% |
4,549 |
139.65 |
| VXX |
iPath S&P 500 VIX Short-Term Futures ETN |
1.57% |
35,889,472 |
1,972.91 |
| VIXM |
ProShares VIX Mid-term |
1.56% |
16,176 |
109.68 |
| VIIX |
VelocityShares VIX Short Term ETN |
1.42% |
259,300 |
26.67 |
| BBH |
Market Vectors Biotech |
1.34% |
33,255 |
107.43 |
| IBB |
iShares NASDAQ Biotechnology |
1.33% |
948,693 |
1,807.66 |
Bottom 10 1-Day Performers, Excluding Leverage/Inverse
Funds and 'lt;1,000 Shares Traded
| Ticker |
Name |
1-Day Performance |
1-Day Volume |
AUM ($, mm) |
| FGEM |
EGShares Financials GEMS |
-5.15% |
2,000 |
3.76 |
| KBWC |
PowerShares KBW Capital Markets Portfolio |
-4.55% |
1,100 |
1.54 |
| BAL |
iPath Dow Jones-UBS Cotton Total Return ETN |
-3.57% |
55,744 |
32.29 |
| SOYB |
Teucrium Soybeans |
-3.35% |
6,289 |
4.62 |
| DBBR |
db-X MSCI Brazil Currency-Hedged Equity |
-3.31% |
1,600 |
4.34 |
| VNM |
Market Vectors Vietnam |
-3.27% |
148,887 |
349.17 |
| AGF |
PowerShares DB Agriculture Long ETN |
-3.13% |
2,400 |
10.23 |
| GGGG |
Global X PURE Gold Miners |
-3.00% |
5,200 |
4.12 |
| PEK |
Market Vectors China |
-2.84% |
1,100 |
16.90 |
| GLDX |
Global X Gold Explorers |
-2.64% |
21,031 |
27.51 |
Disclaimer:All data as of 6 a.m. Eastern time the date the
article is published. Data is believed to be accurate; however,
transient market data is often subject to subsequent revision and
correction by the exchanges.
Permalink | 'copy; Copyright 2009 IndexUniverse LLC. All rights
reserved
Don't forget to check IndexUniverse.com's ETF Data
section.
Copyright ®
2012 IndexUniverse LLC
. All Rights Reserved.